Table 4

Age, sex, and income and utilisation of potentially inappropriate psychotropics among the study participants (n = 384346).

PIP, No./Total N (%)†

Odds Ratio (95% CI)‡

p-value

Adjusted Odds Ratio (95% CI)§

p-value


Age

75-79

45788/111787 (41.0)

1 (Reference)

1 (Reference)

80-84

46658/115802 (40.3)

0.95 (0.93-0.96)

< 0.001

0.93 (0.91-0.94)

< 0.001

85+

58171/137798 (42.2)

0.95 (0.93-0.96)

< 0.001

0.91 (0.90-0.93)

< 0.001

Sex

Men

47997/112602 (42.6)

1 (Reference)

1 (Reference)

Women

102620/252786 (40.6)

0.96 (0.95-0.97)

< 0.001

0.94 (0.93-0.95)

< 0.001

Income*

High

48027/121784 (39.4)

1 (Reference)

1 (Reference)

Middle

51491/124009 (41.5)

1.07 (1.06-1.09)

< 0.001

1.08 (1.07-1.10)

< 0.001

Low

50983/119233 (42.8)

1.10 (1.08-1.12)

< 0.001

1.14 (1.13-1.16)

< 0.001


PIP: Potentially inappropriate psychotropic drugs

* Family disposable income for year 2005, adjusted for family size.

† The denominator was adjusted for the proportion of days the population was resident in the country and alive during 2006

‡ Adjusted for the proportion of days resident in the country and alive during 2006

§Adjusted for age, sex, income, country of birth, proportion of days resident in the country and alive during 2006, and number of unique nonpsychotropic drug substances purchased during the study period.

Lesén et al. BMC Public Health 2010 10:118   doi:10.1186/1471-2458-10-118

Open Data